Merck KGaA Ties Up Chord To Advance Cladribine Rare Disease Programs

Acquires Swiss Biotech To Expand Neurology Pipeline

 
• By Kevin Grogan
merck kgaa
The Darmstadt-based group is looking for bolt-ons • Source: merck kgaa

More from Deals

More from Business